Four domestic crown disease vaccines in China were approved urgently within two days

China has four domestic coronary vaccines in two days.There are currently 13 domestic crown vaccines in China.Not According to the 21st Century Business Herald, two vaccines incorporated into the emergency use on Monday (December 5) are the coronary vaccine developed by the nasal injection virus carrier developed by Wantai Biological Cooperation and the Huaxi Hospital and Chengdu of Sichuan University and Chengdu.The reorganized coronary protein vaccine (SF9 cell) developed by Westk Biological Co., Ltd.Not The two vaccines approved by Sunday (December 4) are crown disease vaccines of clover creatures.Alpha/Beta mutant) S trimorerin vaccine (SCTV01C).Not According to incomplete statistics, 13 vaccines have been approved in China.Biology, Kangtai Biology, Wantai Biology, Shenzhou cells, clover biology, Wesk creature, etc.The global vaccine technology route accounts for a relatively high MRNA coronary vaccine, and there is currently no approval of local Chinese companies.Not According to public information, at least ten companies such as Chinese medicine recovered Nuojian, Stone Medicine Group, Siwei Bio, Aibo Biology, Lvfanda Bio, Bluebird Bio, Kangshino and other companies are developing the MRNA crownDisease vaccine.Not Guo Yanhong, director of the Medical Emergency Department of the National Health and Health Commission of China, said on November 29 that vaccination can effectively reduce the risk of severe illnesses and death.Campaign vaccine as soon as possible.Not The Chinese State Council formulated a plan to strengthen the new crown virus vaccination work on November 29, proposed that it should continue to increase the crown vaccine over 60 years of age Span> The vaccination rate and enhanced needle vaccination rate .